title: Characterisation and cytotoxic screening of metal oxide nanoparticles putative of interest to oral healthcare formulations in non-keratinised human oral mucosa cells in vitro.
abstract: Nanoparticles are increasingly being utilised in the innovation of consumer product formulations to improve their characteristics; however, established links between their properties, dose and cytotoxicity are not well defined. The purpose of this study was to screen four different nanomaterials of interest to oral care product development in the absence of stabilisers, alongside their respective bulk equivalents, within a non-keratinised oral epithelial cell model (H376). Particle morphology and size were characterised using scanning electron microscopy (SEM) and dynamic light scattering (DLS). The H376 model showed that zinc oxide (ZnO) was the most cytotoxic material at concentrations exceeding 0.031% w/v, as assessed using the lactate dehydrogenase (LDH) and dimethylthiazolyl-diphenyl-tetrazolium-bromide (MTT) assays. ZnO cytotoxicity does not appear to be dependent upon size of the particle; a result supported by SEM of cell-particle interactions. Differences in cytotoxicity were observed between the bulk and nanomaterial forms of hydroxyapatite and silica (SiO2); titanium dioxide (TiO2) was well tolerated in both forms at the doses tested. Overall, nano-size effects have some impact on the cytotoxicity of a material; however, these may not be as significant as chemical composition or surface properties. Our data highlights the complexities involved at the nano-scale, in both the characterisation of materials and in relation to cytotoxic properties exerted on oral epithelial cells.
authors.affiliation: School of Pharmacy & Biomolecular Science, University of Brighton, Brighton, UK. Electronic address: M.Best2@brighton.ac.uk.
authors.forename: M
authors.initials: M
authors.lastname: Best
authors.affiliation: School of Pharmacy & Biomolecular Science, University of Brighton, Brighton, UK.
authors.forename: G
authors.initials: G
authors.lastname: Phillips
authors.affiliation: GlaxoSmithKline Consumer Healthcare R&D, Weybridge, Surrey, UK.
authors.forename: C
authors.initials: C
authors.lastname: Fowler
authors.affiliation: GlaxoSmithKline Consumer Healthcare R&D, Weybridge, Surrey, UK.
authors.forename: J
authors.initials: J
authors.lastname: Rowland
authors.affiliation: School of Pharmacy & Biomolecular Science, University of Brighton, Brighton, UK.
authors.forename: J
authors.initials: J
authors.lastname: Elsom
mesh_terms: D002478:Cells, Cultured; D002626:Chemistry, Pharmaceutical; D006801:Humans; D053768:Metal Nanoparticles / Q000633:toxicity*; D009061:Mouth Mucosa / Q000187:drug effects* / Q000473:pathology; D010316:Particle Size; D015034:Zinc Oxide / Q000633:toxicity*
chemical_list: D015034:Zinc Oxide
keywords: Hydroxyapatite; Nanoparticle; Non-keratinised; Oral mucosa cell; Silica; Titanium dioxide; Zinc oxide